The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 3,501 | 808,431 | SH | SOLE | 808,431 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 1,277 | 219,340 | SH | SOLE | 219,340 | 0 | 0 | ||
| AMRYT PHARMA LTD - SPNR ADR | SPONSORED ADS | 03217L106 | 20,057 | 1,416,483 | SH | SOLE | 1,416,483 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 7,909 | 2,326,165 | SH | SOLE | 2,326,165 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM NEW | 03835L207 | 670 | 18,280 | SH | SOLE | 18,280 | 0 | 0 | ||
| AYTU BIOSCIENCE INC | COM | 054754874 | 8,365 | 1,398,776 | SH | SOLE | 1,398,776 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 5,265 | 834,449 | SH | SOLE | 834,449 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 3,138 | 721,307 | SH | SOLE | 721,307 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 557 | 188,703 | SH | SOLE | 188,703 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 6,614 | 2,054,000 | SH | SOLE | 2,054,000 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 9,633 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 3,184 | 379,470 | SH | SOLE | 379,470 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 5,528 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 32,431 | 326,100 | SH | SOLE | 326,100 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 3,100 | 4,962,657 | SH | SOLE | 4,962,657 | 0 | 0 | ||
| NOVUS THERAPEUTICS INC | COM | 67011N204 | 2,577 | 167,333 | SH | SOLE | 167,333 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 3,281 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
| SCYNEXIS INC | COM NEW | 811292200 | 5,240 | 685,000 | SH | SOLE | 685,000 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 970 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 5,478 | 124,130 | SH | SOLE | 124,130 | 0 | 0 | ||
| YUMANITY THERAPEUTICS INC | COM | 98872L102 | 1,850 | 108,847 | SH | SOLE | 108,847 | 0 | 0 | ||